Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy A Translational Perspective

Stanley Nattel*, Jordi Heijman, Liping Zhou, Dobromir Dobrev*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

102 Citations (Web of Science)

Abstract

Atrial fibrillation (AF) is a highly prevalent arrhythmia, with substantial associated morbidity and mortality. There have been significant management advances over the past 2 decades, but the burden of the disease continues to increase and there is certainly plenty of room for improvement in treatment options. A potential key to therapeutic innovation is a better understanding of underlying fundamental mechanisms. This article reviews recent advances in understanding the molecular basis for AF, with a particular emphasis on relating these new insights to opportunities for clinical translation. We first review the evidence relating basic electrophysiological mechanisms to the characteristics of clinical AF. We then discuss the molecular control of factors leading to some of the principal determinants, including abnormalities in impulse conduction (such as tissue fibrosis and other extra-cardiomyocyte alterations, connexin dysregulation and Na+-channel dysfunction), electrical refractoriness, and impulse generation. We then consider the molecular drivers of AF progression, including a range of Ca2+-dependent intracellular processes, microRNA changes, and inflammatory signaling. The concept of key interactome-related nodal points is then evaluated, dealing with systems like those associated with CaMKII (Ca2+/calmodulin-dependent protein kinase-II), NLRP3 (NACHT, LRR, and PYD domains-containing protein-3), and transcription-factors like TBX5 and PitX2c. We conclude with a critical discussion of therapeutic implications, knowledge gaps and future directions, dealing with such aspects as drug repurposing, biologicals, multispecific drugs, the targeting of cardiomyocyte inflammatory signaling and potential considerations in intervening at the level of interactomes and gene-regulation. The area of molecular intervention for AF management presents exciting new opportunities, along with substantial challenges.

Original languageEnglish
Pages (from-to)51-72
Number of pages22
JournalCirculation Research
Volume127
Issue number1
DOIs
Publication statusPublished - 19 Jun 2020

Keywords

  • atrial fibrillation
  • calcium
  • inflammasome
  • myocytes
  • cardiac
  • transcription factors
  • RECTIFIER POTASSIUM CURRENT
  • SHORT-QT SYNDROME
  • SR CA2+ LEAK
  • DELAYED AFTERDEPOLARIZATIONS
  • PULMONARY VEINS
  • CELLULAR ELECTROPHYSIOLOGY
  • CONTRACTILE DYSFUNCTION
  • SARCOPLASMIC-RETICULUM
  • TRIGGERED ACTIVITY
  • PRESSURE-OVERLOAD

Cite this